% Expired Patents = 10.0

EPO Patents = 1

Forward Citations = 23

Loading Chart...

1 inventor (with patents filed for the assignee):

Dale R Cameron (10 out of 27 patents)

Dale R Cameron (0 patent)

10 patents: Sort by Forward Citations

1. 10537652 - Cyclic urea compounds as granzyme B inhibitors (2020-01-21),

2. 10329324 - Indoline compounds as granzyme B inhibitors (2019-06-25),

3. 10246487 - Azaindoline compounds as granzyme B inhibitors (2019-04-02),

4. 9969772 - Covalent granzyme B inhibitors (2018-05-15),

5. 9969770 - Proline compounds as Granzyme B inhibitors (2018-05-15),

6. 9849112 - Pyrrole compounds as Granzyme B inhibitors (2017-12-26),

7. 9605021 - Indoline compounds as granzyme B inhibitors (2017-03-28),

8. 9458193 - Proline compounds as Granzyme B inhibitors (2016-10-04),

9. 9458192 - Covalent granzyme B inhibitors (2016-10-04),

10. 9458138 - Pyrrole compounds as granzyme B inhibitors (2016-10-04),

Vida Therapeutics Inc. is a biotechnology company focused on developing innovative treatments for various diseases, with a primary focus on autoimmune disorders and inflammatory conditions. Our mission is to improve the lives of patients by providing breakthrough therapies that target the root cause of their illnesses. Through cutting-edge research and strategic partnerships, we aim to bring novel therapies to market that have the potential to transform healthcare. Visit our website to learn more about our pipeline and team.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

10 Patents

#95 in Vancouver

#1,521 in Canada

#55,954 in the World

Vancouver, Canada

Vida Therapeutics Inc.

Forward Citations = 23

1 inventor:

Dale R Cameron (10 out of 27 patents)

Dale R Cameron (0 patent)

Please report any incorrect information to [email protected]

1 patent (EPO):

Please report any incorrect information to [email protected]